1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Imbruvica Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 5 mg 1.2.3 10 mg 1.2.4 140 mg 1.3 Market by Application 1.3.1 Global Imbruvica Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Mantle Cell Lymphoma 1.3.3 Chronic Lymphocytic Leukemia 1.3.4 Waldenström's Macroglobulinemia 1.3.5 Relapsed/Refractory Marginal Zone Lymphoma 1.3.6 Chronic Graft-Versus-Host-Disease 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Imbruvica Market Perspective (2016-2027) 2.2 Imbruvica Growth Trends by Regions 2.2.1 Imbruvica Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Imbruvica Historic Market Share by Regions (2016-2021) 2.2.3 Imbruvica Forecasted Market Size by Regions (2022-2027) 2.3 Imbruvica Industry Dynamic 2.3.1 Imbruvica Market Trends 2.3.2 Imbruvica Market Drivers 2.3.3 Imbruvica Market Challenges 2.3.4 Imbruvica Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Imbruvica Players by Revenue 3.1.1 Global Top Imbruvica Players by Revenue (2016-2021) 3.1.2 Global Imbruvica Revenue Market Share by Players (2016-2021) 3.2 Global Imbruvica Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Imbruvica Revenue 3.4 Global Imbruvica Market Concentration Ratio 3.4.1 Global Imbruvica Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Imbruvica Revenue in 2020 3.5 Imbruvica Key Players Head office and Area Served 3.6 Key Players Imbruvica Product Solution and Service 3.7 Date of Enter into Imbruvica Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Imbruvica Breakdown Data by Type 4.1 Global Imbruvica Historic Market Size by Type (2016-2021) 4.2 Global Imbruvica Forecasted Market Size by Type (2022-2027) 5 Imbruvica Breakdown Data by Application 5.1 Global Imbruvica Historic Market Size by Application (2016-2021) 5.2 Global Imbruvica Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Imbruvica Market Size (2016-2027) 6.2 North America Imbruvica Market Size by Type 6.2.1 North America Imbruvica Market Size by Type (2016-2021) 6.2.2 North America Imbruvica Market Size by Type (2022-2027) 6.2.3 North America Imbruvica Market Size by Type (2016-2027) 6.3 North America Imbruvica Market Size by Application 6.3.1 North America Imbruvica Market Size by Application (2016-2021) 6.3.2 North America Imbruvica Market Size by Application (2022-2027) 6.3.3 North America Imbruvica Market Size by Application (2016-2027) 6.4 North America Imbruvica Market Size by Country 6.4.1 North America Imbruvica Market Size by Country (2016-2021) 6.4.2 North America Imbruvica Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Imbruvica Market Size (2016-2027) 7.2 Europe Imbruvica Market Size by Type 7.2.1 Europe Imbruvica Market Size by Type (2016-2021) 7.2.2 Europe Imbruvica Market Size by Type (2022-2027) 7.2.3 Europe Imbruvica Market Size by Type (2016-2027) 7.3 Europe Imbruvica Market Size by Application 7.3.1 Europe Imbruvica Market Size by Application (2016-2021) 7.3.2 Europe Imbruvica Market Size by Application (2022-2027) 7.3.3 Europe Imbruvica Market Size by Application (2016-2027) 7.4 Europe Imbruvica Market Size by Country 7.4.1 Europe Imbruvica Market Size by Country (2016-2021) 7.4.2 Europe Imbruvica Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Imbruvica Market Size (2016-2027) 8.2 Asia-Pacific Imbruvica Market Size by Type 8.2.1 Asia-Pacific Imbruvica Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Imbruvica Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Imbruvica Market Size by Type (2016-2027) 8.3 Asia-Pacific Imbruvica Market Size by Application 8.3.1 Asia-Pacific Imbruvica Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Imbruvica Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Imbruvica Market Size by Application (2016-2027) 8.4 Asia-Pacific Imbruvica Market Size by Region 8.4.1 Asia-Pacific Imbruvica Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Imbruvica Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Imbruvica Market Size (2016-2027) 9.2 Latin America Imbruvica Market Size by Type 9.2.1 Latin America Imbruvica Market Size by Type (2016-2021) 9.2.2 Latin America Imbruvica Market Size by Type (2022-2027) 9.2.3 Latin America Imbruvica Market Size by Type (2016-2027) 9.3 Latin America Imbruvica Market Size by Application 9.3.1 Latin America Imbruvica Market Size by Application (2016-2021) 9.3.2 Latin America Imbruvica Market Size by Application (2022-2027) 9.3.3 Latin America Imbruvica Market Size by Application (2016-2027) 9.4 Latin America Imbruvica Market Size by Country 9.4.1 Latin America Imbruvica Market Size by Country (2016-2021) 9.4.2 Latin America Imbruvica Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Imbruvica Market Size (2016-2027) 10.2 Middle East & Africa Imbruvica Market Size by Type 10.2.1 Middle East & Africa Imbruvica Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Imbruvica Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Imbruvica Market Size by Type (2016-2027) 10.3 Middle East & Africa Imbruvica Market Size by Application 10.3.1 Middle East & Africa Imbruvica Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Imbruvica Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Imbruvica Market Size by Application (2016-2027) 10.4 Middle East & Africa Imbruvica Market Size by Country 10.4.1 Middle East & Africa Imbruvica Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Imbruvica Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie (Pharmacyclics) 11.1.1 AbbVie (Pharmacyclics) Company Details 11.1.2 AbbVie (Pharmacyclics) Business Overview 11.1.3 AbbVie (Pharmacyclics) Imbruvica Introduction 11.1.4 AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2016-2021) 11.1.5 AbbVie (Pharmacyclics) Recent Development 11.2 Johnson & Johnson (Janssen Biotech) 11.2.1 Johnson & Johnson (Janssen Biotech) Company Details 11.2.2 Johnson & Johnson (Janssen Biotech) Business Overview 11.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Introduction 11.2.4 Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2016-2021) 11.2.5 Johnson & Johnson (Janssen Biotech) Recent Development 11.3 SP Laboratories 11.3.1 SP Laboratories Company Details 11.3.2 SP Laboratories Business Overview 11.3.3 SP Laboratories Imbruvica Introduction 11.3.4 SP Laboratories Revenue in Imbruvica Business (2016-2021) 11.3.5 SP Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Imbruvica Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of 5 mg Table 3. Key Players of 10 mg Table 4. Key Players of 140 mg Table 5. Global Imbruvica Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Imbruvica Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Imbruvica Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Imbruvica Market Share by Regions (2016-2021) Table 9. Global Imbruvica Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Imbruvica Market Share by Regions (2022-2027) Table 11. Imbruvica Market Trends Table 12. Imbruvica Market Drivers Table 13. Imbruvica Market Challenges Table 14. Imbruvica Market Restraints Table 15. Global Imbruvica Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Imbruvica Market Share by Players (2016-2021) Table 17. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imbruvica as of 2020) Table 18. Ranking of Global Top Imbruvica Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Imbruvica Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Imbruvica Product Solution and Service Table 22. Date of Enter into Imbruvica Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Imbruvica Market Size by Type (2016-2021) (US$ Million) Table 25. Global Imbruvica Revenue Market Share by Type (2016-2021) Table 26. Global Imbruvica Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Imbruvica Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Imbruvica Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Imbruvica Revenue Market Share by Application (2016-2021) Table 30. Global Imbruvica Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Imbruvica Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Imbruvica Market Size by Type (2016-2021) (US$ Million) Table 33. North America Imbruvica Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Imbruvica Market Size by Application (2016-2021) (US$ Million) Table 35. North America Imbruvica Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Imbruvica Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Imbruvica Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Imbruvica Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Imbruvica Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Imbruvica Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Imbruvica Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Imbruvica Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Imbruvica Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Imbruvica Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Imbruvica Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Imbruvica Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Imbruvica Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Imbruvica Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Imbruvica Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Imbruvica Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Imbruvica Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Imbruvica Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Imbruvica Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Imbruvica Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Imbruvica Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Imbruvica Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Imbruvica Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Imbruvica Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Imbruvica Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Imbruvica Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Imbruvica Market Size by Country (2022-2027) & (US$ Million) Table 62. AbbVie (Pharmacyclics) Company Details Table 63. AbbVie (Pharmacyclics) Business Overview Table 64. AbbVie (Pharmacyclics) Imbruvica Product Table 65. AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2016-2021) & (US$ Million) Table 66. AbbVie (Pharmacyclics) Recent Development Table 67. Johnson & Johnson (Janssen Biotech) Company Details Table 68. Johnson & Johnson (Janssen Biotech) Business Overview Table 69. Johnson & Johnson (Janssen Biotech) Imbruvica Product Table 70. Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2016-2021) & (US$ Million) Table 71. Johnson & Johnson (Janssen Biotech) Recent Development Table 72. SP Laboratories Company Details Table 73. SP Laboratories Business Overview Table 74. SP Laboratories Imbruvica Product Table 75. SP Laboratories Revenue in Imbruvica Business (2016-2021) & (US$ Million) Table 76. SP Laboratories Recent Development Table 77. Research Programs/Design for This Report Table 78. Key Data Information from Secondary Sources Table 79. Key Data Information from Primary Sources List of Figures Figure 1. Global Imbruvica Market Share by Type: 2020 VS 2027 Figure 2. 5 mg Features Figure 3. 10 mg Features Figure 4. 140 mg Features Figure 5. Global Imbruvica Market Share by Application: 2020 VS 2027 Figure 6. Mantle Cell Lymphoma Case Studies Figure 7. Chronic Lymphocytic Leukemia Case Studies Figure 8. Waldenström's Macroglobulinemia Case Studies Figure 9. Relapsed/Refractory Marginal Zone Lymphoma Case Studies Figure 10. Chronic Graft-Versus-Host-Disease Case Studies Figure 11. Imbruvica Report Years Considered Figure 12. Global Imbruvica Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Imbruvica Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Imbruvica Market Share by Regions: 2020 VS 2027 Figure 15. Global Imbruvica Market Share by Regions (2022-2027) Figure 16. Global Imbruvica Market Share by Players in 2020 Figure 17. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imbruvica as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Imbruvica Revenue in 2020 Figure 19. Global Imbruvica Revenue Market Share by Type (2016-2021) Figure 20. Global Imbruvica Revenue Market Share by Type (2022-2027) Figure 21. North America Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Imbruvica Market Share by Type (2016-2027) Figure 23. North America Imbruvica Market Share by Application (2016-2027) Figure 24. North America Imbruvica Market Share by Country (2016-2027) Figure 25. United States Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Imbruvica Market Share by Type (2016-2027) Figure 29. Europe Imbruvica Market Share by Application (2016-2027) Figure 30. Europe Imbruvica Market Share by Country (2016-2027) Figure 31. Germany Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Imbruvica Market Share by Type (2016-2027) Figure 39. Asia-Pacific Imbruvica Market Share by Application (2016-2027) Figure 40. Asia-Pacific Imbruvica Market Share by Region (2016-2027) Figure 41. China Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Imbruvica Market Share by Type (2016-2027) Figure 49. Latin America Imbruvica Market Share by Application (2016-2027) Figure 50. Latin America Imbruvica Market Share by Country (2016-2027) Figure 51. Mexico Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Imbruvica Market Share by Type (2016-2027) Figure 55. Middle East & Africa Imbruvica Market Share by Application (2016-2027) Figure 56. Middle East & Africa Imbruvica Market Share by Country (2016-2027) Figure 57. Turkey Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Imbruvica Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. AbbVie (Pharmacyclics) Revenue Growth Rate in Imbruvica Business (2016-2021) Figure 61. Johnson & Johnson (Janssen Biotech) Revenue Growth Rate in Imbruvica Business (2016-2021) Figure 62. SP Laboratories Revenue Growth Rate in Imbruvica Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

AbbVie (Pharmacyclics) Johnson & Johnson (Janssen Biotech) SP Laboratories